Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Daniel D. Murray, Abdel G. Babiker, Jason V. Baker, Christina E. Barkauskas, Samuel M. Brown, Christina C. Chang, Victoria J. Davey, Annetine C. Gelijns, Adit A. Ginde, Birgit Grund, Elizabeth Higgs, Fleur Hudson, Virginia L. Kan, H. Clifford Lane, Thomas A. Murray, Roger Paredes, Mahesh K.B. Parmar, Sarah Pett, Andrew N. Phillips, Mark N. Polizzotto, Cavan Reilly, Uriel Sandkovsky, Shweta Sharma, Marc Teitelbaum, B. Taylor Thompson, Barnaby E. Young, James D. Neaton, Jens D. Lundgren
medRxiv 2020.11.08.20227876; doi: https://doi.org/10.1101/2020.11.08.20227876